Association between smoking and cognitive impairment in multiple sclerosis

Neuropsychiatric Disease and Treatment

Volumn 10, Issue , 2014, Pages 1715-1719

  Özcan, Muhammed Emin ^a   Ince, Bahri ^b   Bingöl, Ayhan ^c   Ertürk, Simge ^c   Altınöz, Meriç Adil ^d   Karadeli, Hasan Hüseyin ^a   Koçer, Abdulkadir ^e   Asil, Talip ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Mayis Psychology Center   (Turkey)

^d HALIC UNIVERSITY   (Turkey)

^e ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

Author keywords

BRB N; Cigarette; Cognition; Memory; Mentation; Nicotine; Tobacco

Indexed keywords

ADULT; AGED; ARTICLE; BRIEF REPEATABLE BATTERY OF NEUROPSYCHOLOGICAL TEST; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PACED AUDITORY SERIAL ADDITION TEST SCORE; PREVALENCE; RELAPSE; RISK FACTOR; SCORING SYSTEM; SMOKING; SYMBOL DIGIT MODALITIES TEST SCORE; THINKING;

EID: 84907190241     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S68389     Document Type: Article

References (30)

1. Pelosi L, Geesken JM, Holly M, Hayward M, Blumhardt LD. Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain. 1997;120:2039–2058.
2. Rao S, Leo G, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis: frequency, patterns, and predictions. Neurology. 1991;41: 685–691.
3. Beatty WM, Blanco CR, Wilbanks SL, Paul RH, Hames KA. Demographic, clinical, and cognitive characteristics of multiple sclerosis patients who continue to work. J Neurol Rehab. 1995;9:167–173.
4. Pierson SH, Griffth N. Treatment of cognitive impairment in multiple sclerosis. Behav Neurol. 2006;17(1):53–67.
5. Jafari N, Hintzen RQ. The association between cigarette smoking and multiple sclerosis. J Neurol Sci. 2011;311(1–2):78–85.
6. Di Pauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler. 2008;14(8): 1026–1030.
7. D’hooghe MB, Nagels G, Bissay V, De Keyser J. Modifiable factors infuencing relapses and disability in multiple sclerosis. Mult Scler. 2010; 16(7):773–785.
8. Pittas F, Ponsonby AL, van der Mei IA, et al. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol. 2009;256(4):577–585.
9. Wignall ND, de Wit H. Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Exp Clin Psychopharmacol. 2011;19(3): 183–191.
10. Rusted JM, Sawyer R, Jones C, et al. Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psy-chopharmacology (Berl). 2009;202(1–3):93–102.
11. Ghaffar O, Feinstein A. Multiple sclerosis and cannabis: a cognitive and psychiatric study. Neurology. 2008;71(3):164–169.
12. Papathanasopoulos P, Messinis L, Lyros E, Kastellakis A, Panagis G. Multiple sclerosis, cannabinoids, and cognition. J Neuropsychiatry Clin Neurosci. 2008;20(1):36–51.
13. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.
14. Friend KB, Mernoff ST, Block P, Reeve G. Smoking rates and smoking cessation among individuals with multiple sclerosis. Disabil Rehabil. 2006;28(18):1135–1141.
15. Portaccio E, Goretti B, Zipoli V, et al. Reliability, practice effects and change indices for Rao’ s brief repeatable battery. Mult Scler. 2010;16: 611–617.
16. Bingöl A, Yıldız Ş, Topçular B, et al. Brief repeatable battery (BRB) Turkish normative data. Eur J Neurol. 2012;19(Suppl 1):458–807.
17. Caldirola D, Daccò S, Grassi M, et al. Effects of cigarette smoking on neuropsychological performance in mood disorders: a comparison between smoking and nonsmoking inpatients. J Clin Psychiatry. 2013;74(2):e130–e136.
18. Yoneda I, Watanabe Y. Comparisons of altitude tolerance and hypoxia symptoms between nonsmokers and habitual smokers. Aviat Space Environ Med. 1997;68(9):807–811.
19. Chamberlain SR, Odlaug BL, Schreiber LR, Grant JE. Association between tobacco smoking and cognitive functioning in young adults. Am J Addict. 2012;21(1):S14–S19.
20. Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health. 2010;7(10):3760–3091.
21. Shirani A, Tremlett H. The effect of smoking on the symptoms and progression of multiple sclerosis: a review. J Infamm Res. 2010;3: 115–126.
22. Sundström P, Nyström L. Smoking worsens the prognosis in multiple sclerosis. Mult Scler. 2008;14(8):1031–1035.
23. Results of the Global Adult Tobacco Survey [webpage on the Internet]. Ankara, Turkey: Republic of Turkey Turkish Statistical Institute; 2012. Available from: http://www.turkstat.gov.tr/PreHaberBultenleri.do?id=13142. Accessed May 24, 2014.
24. Rao SM, Grafman J, DiGiulio D, et al. Memory dysfunction in multiple sclerosis: Its relation to working memory, semantic encoding, and implicit learning. Neuropsychology. 1993;7(3):364–374.
25. Brochet B, Deloire MS, Bonnet M, et al. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study. Mult Scler. 2008;14(9): 1242–1249.
26. Savettieri G, Messina D, Andreoli V, et al. Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol. 2004;251(10):1208–1214.
27. Borghi M, Cavallo M, Carletto S, et al. Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. PLoS One. 2013;8(7):e69820.
28. Anstey KJ, von Sanden C, Salim A, O’Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol. 2007;166:367–378.
29. Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler. 2011;17(7):788–793.
30. Hedström AK, Hillert J, Olsson T, Alfredsson L. Nicotine might have a protective effect in the etiology of multiple sclerosis. Mult Scler. 2013; 19(8):1009–1013.